Cancer gene therapy using a pro-apoptotic gene, caspase-3

Gene Therapy

Volumn 6, Issue 12, 1999, Pages 1952-1959

  Yamabe, K ^a   Shimizu, S ^a   Ito, T ^a   Yoshioka, Y ^a   Nomura, M ^a   Narita, M ^a   Saito, I ^b   Kanegae, Y ^b   Matsuda, H ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anticancer gene therapy; Bcl 2; Caspase 3 gene; Recombinant adenovirus vector

Indexed keywords

CASPASE 3; ETOPOSIDE; PROTEIN BCL 2; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LIVER TUMOR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL; TUMOR VOLUME;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; COMBINED MODALITY THERAPY; ETOPOSIDE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IN SITU NICK-END LABELING; LIVER NEOPLASMS, EXPERIMENTAL; NEOPLASM TRANSPLANTATION; NUCLEIC ACID SYNTHESIS INHIBITORS; RATS; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA;

EID: 0033393502     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301041     Document Type: Article

References (20)

1. Fernandes-Alnemri T, Liwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-cconverting enzyme. J Biol Chem 1994; 269: 30761-30766.
2. Tewari M et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81: 801-809.
3. Nicholson DW et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
4. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts? Cell 1995; 82: 349-352.
5. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 1997; 91: 443-446.
6. Kuida K et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384: 368-372.
7. Hasegawa J et al. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis. Cancer Res 1996; 56: 1713-1718.
8. Enari M, Talanian RV, Wong WW, Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fasmediated apoptosis. Nature 1996; 380: 723-726.
9. Miyake S et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 1996; 93: 1320-1324.
10. Kanegae Y et al. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 1995; 23: 3816-3821.
11. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high expression transductants with a novel eukaryotic vector. Gene 1991; 108: 193-200.
12. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440-442.
13. Tsujimoto Y. Stress-resistance conferred by high level of bcl-2 alpha protein in human B lymphoblastoid cell. Oncogene 1989; 4: 1331-1336.
14. Nunez G et al. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990; 144: 3602-3610.
15. Chinnaiyan AM et al. Molecular ordering of the cell death pathway: Bcl-2 and Bcl-xL function upstream of the Ced-3-like apoptotic proteases. J Biol Chem 1996; 271: 4573-4576.
16. Shimizu S et al. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene 1996; 12: 2251-2257.
17. Shimizu S et al. Bcl-2 prevents mitochondrial potential loss by regulating ion flux. Proc Natl Acad Sci USA 1998; 95: 1455-1459.
18. Faleiro L, Kobayashi R, Fearnhead H, Lazebnik Y. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBJO J 1997; 16: 2271-2281.
19. Colussi PA, Harvey NL, Shearwin-Whyatt LM, Kumar SJ. Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain. J Biol Chem 1998; 273: 26566-26570.
20. Shimizu S et al. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible common mediators in apoptotic and necrotic signal transduction. Oncogene 1996; 12: 2045-2050.